Sign Up for Free!

Continue Analyzing the page and more.

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

Avricore Health Inc. logo

Avricore Health Inc.

US$0.05

US$4.8m

7.80%

13.53%

Dashboard Funda..tals Deep..lue Prediction Screener Map

Avricore Health Inc. Overview

Industry: Diagnostics & Research

Sector: Healthcare

Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a lab-accurate point of care testing platform for pharmacy. The company has strategic partnerships with Shoppers Drug Marts and Abbott. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.

Avricore Health Inc. is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.

Score

Price History & Performance

Review Avricore Health Inc. in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.

Recent News



Avricore Health Inc. Competitors

Avricore Health Inc. operates in the Diagnostics & Research industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.

Earnings Per Share

EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.

Continue the analysis

Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.

View plans
Ticker Image

Avricore Health Inc.

US$0.05

US$4.8m

7.80%

13.53%